Literature DB >> 20609643

Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.

Mario Sénéchal1, Patrizio Lancellotti, Julien Magne, Patrick Garceau, Jean Champagne, François Philippon, Gilles O'Hara, Marie Moonen, Michelle Dubois.   

Abstract

This study investigated the impact of ischemic mitral regurgitation (MR) severity and viability on left ventricular (LV) reverse remodeling after cardiac resynchronization therapy (CRT) in patients with ischemic cardiomyopathy. Severe MR and ischemic cardiomyopathy have been associated with lack of LV reverse remodeling after CRT. Fifty-seven consecutive patients with ischemic MR, LV ejection fraction < or =35%, QRS duration > or =120 ms, and intraventricular dyssynchrony > or =50 ms were prospectively included. Stress echocardiography was performed before CRT implantation. Viability in the region of the LV pacing lead was defined as the presence of viability in 2 contiguous segments. Response to CRT at 6 months was defined by evidence of > or =15% LV decrease in end-systolic volume. Severe MR was defined by an effective regurgitant orifice (ERO) area > or =20 mm(2). Thirty-three patients (58%) were responders at follow-up. Baseline ERO area and prevalence of severe MR were not different between responders and nonresponders (19 +/- 11 vs 21 +/- 13 mm(2), p = 0.67; 52% vs 53%, p = 0.84). In responders, MR was decreased by 58% (ERO 19 +/- 12 to 8 +/- 6 mm(2)). In the presence of viability in the region of the pacing lead, 74% (n = 29 patients) were responders (sensitivity 88%, specificity 58%); in the subgroup of patients with viability in the region of the pacing lead and severe MR, 83% (n = 17 patients) were responders. In conclusion, LV remodeling is frequent and ischemic MR decrease important in patients with viability in the region of the pacing lead without regard to MR severity. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609643     DOI: 10.1016/j.amjcard.2010.02.012

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Therapeutic decision-making for patients with fluctuating mitral regurgitation.

Authors:  Patrizio Lancellotti; Khalil Fattouch; Giovanni La Canna
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

Review 2.  Left ventricular dyssynchrony: a dynamic condition.

Authors:  Patrizio Lancellotti; Marie Moonen
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 3.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

4.  Impact of septal flash and left ventricle contractile reserve on positive remodeling during 1 year cardiac resynchronization therapy: the multicenter ViaCRT study.

Authors:  Zbigniew Gąsior; Edyta Płońska-Gościniak; Andrzej Kułach; Krystian Wita; Katarzyna Mizia-Stec; Hanna Szwed; Jarosław Kasprzak; Andrzej Tomaszewski; Władysław Sinkiewicz; Celina Wojciechowska
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.